| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,318 |
2,196 |
$164K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,646 |
2,466 |
$143K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,417 |
1,413 |
$129K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,849 |
1,842 |
$119K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,961 |
1,809 |
$56K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
382 |
368 |
$12K |
| 99000 |
|
2,717 |
2,521 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
811 |
417 |
$10K |
| 87428 |
|
260 |
255 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
422 |
414 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
77 |
75 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
27 |
25 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
31 |
31 |
$859.48 |
| 81002 |
|
190 |
184 |
$467.48 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
30 |
28 |
$236.11 |
| 87210 |
|
13 |
13 |
$48.20 |